Table 7.

Quantitative comparison of the results of BD group therapies, where p₀₁ and p₀₂ are therapy agents.

Individual characteristics	Dose value	H 0.81	M 0.52	L 0.23
p 01 = 0.7, p02 = 0.5	H 0.75	P G F = 0.61, GF = 0.55, NF = 0.39	PGF = 0.60, GF = 0.52, NF = 0.40	PGF = 0.60, GF = 0.47, NF = 0.45
	M 0.42	PGF = 0.60, GF = 0.50, NF = 0.42	PGF = 0.60, GF = 0.42, NF = 0.50	PGF = 0.60, GF = 0.45, NF = 0.47
	L 0.26	PGF = 0.60, GF = 0.49, NF = 0.43	PGF = 0.60, GF = 0.39, NF = 0.52	PGF = 0.60, GF = 0.43, NF = 0.49

First column: considered personalize characteristics. Second column: normalized dose value for controlling first characteristic. First row: normalized dose value for controlling 2nd characteristic.